NuVue Therapeutics, Inc.

Home

Company

Milestones

Technologies

Enhanced Ultrasound

Microencapsulation

Cryothermal Effects

Diagnostic Products

ColorMark-A Biopsy Needle

ColorMark-C Biopsy Needle

BrightMark Tissue Markers

Therapeutic Products

ChemoAblator

CryoChemoAblator

NuVue Chemo

Management

Roger Kolasinski

James Stuber

James Kulinski

Patrick Le Pivert

Dennis Morrison

Mark Ehlert

News

510(k) Approval Received

Best Life Sciences Co

Contact

Legal

Mark Ehlert

Mark Ehlert, founder and principal of 315 Ventures, LLC, serves as the Company’s outsourced Director of Corporate Development.  A highly regarded consultant to medical startups in the biosciences & medical device fields, Mr. Ehlert also serves on NuVue’s Board of Directors. As a past Corporate VP with Allegiance, Cardinal Health, and Hospira in Quality Assurance & Regulatory Affairs, Mr. Ehlert has extensive expertise in biotechnology product manufacturing.   Mr. Ehlert earned his bachelor’s degree in microbiology in 1975 at Michigan State University, and has served alongside Mr. Kolasinski over the past ten years on the Dean’s Board of Advisors of the College of Natural Science at the University. 


NuVue Therapeutics, Inc.  Copyright 2011.  All rights reserved.

Website powered by Network Solutions®